COVID-19

Home/ COVID-19

Independent study:SARS-CoV-2 infection in patients with GATA2 deficiency

Dear ESID Member,

We and ESID Board want to pay your immediate attention to an ongoing independent survey by the COVID Human Genetic Effort on the clinical characteristics of SARS-CoV-2 infection in patients with GATA2 deficiency
We consider this an important and timely survey. If your center has such patients,  please consider, whether your center could participate in it.

Independent Survey: SARS-CoV-2 infection in patients with IRAK-4 or MyD88 deficiencies

Dear ESID Member, We at ESID Board want to pay your immediate attention to an ongoing independent survey by the COVID Human Genetic Effort on the clinical characteristics of SARS-CoV-2 infection in patients with IRAK-4 or MyD88 deficiencies. We...

May 2021: Managing COVID in patients with Type 1 IFN pathway defects

May Webinar

Date: Tuesday 18th May

Time: 17:30-18:30 CET

COPID19. Worldwide survey of COVID-19 in PID patients

With the emergence of SARS-CoV-2 and the COVID-19 pandemic, there is an urgent need to understand the impact of infection on immunodeficient individuals. 

The COVID Human Genetic Effort

Dear Friends and Colleagues,
Please find here a study proposal on behalf of Jean-Laurent Casanova, Lab of Human Genetics of Infectious Diseases, The Rockefeller University & HHMI, New York - Necker Hospital for Sick Children & INSERM, Paris.

PID Survey update - COVID-19

The Survey summary on COVID-19 in PID patients can be viewed  here.

Joint statement on the current epidemics of new Coronavirus

Together with IPOPI, INGID, APSID, ASID, ARAPID, CIS, LASID, SEAPID we have worked on a joint statement to provide guidance in advising patients with primary immunodeficiency under our care in the current COVID-19 context.